Dyne.org, RIDDLE&CODE and InfoCert's Consortium Appointed to Take EBSI to the Next Level
21.9.2021 11:05:00 EEST | Business Wire | Press release
The consortium formed by Dyne.org, RIDDLE&CODE and InfoCert, has been selected by the European Commission as one of seven contractors to develop the next version of the European Blockchain Services Infrastructure (EBSI) .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005128/en/
The award is one more milestone in the consortium's track record of excellence with cryptography and blockchain, after Dyne.org led the flagship H2020 project DECODE, RIDDLE&CODE's blockchain solutions are deployed in banking and utility markets Europe wide and InfoCert being the largest Certification Authority at European level and eIDAS certified QTSP.
The European Commission's vision for EBSI is to leverage distributed ledger technologies to create international and intra-communautaire services for public administrations. The European Blockchain Partnership aims to scale the investment fund to a fully developed platform with up to €2 billion in funding.
The consortium led by the non-profit foundation Dyne.org is developing a multilayered network of blockchains for distributed secure execution of smart contracts, including edge-computing scenarios deployed on low-power embedded devices and chips. The blockchain-agnostic solution offers compatibility with a wide range of products to grant freedom of choice to participating member states and solution developers. Existing integrations include BigchainDB, Ethereum, Hyperledger Fabric, Hyperledger Sawtooth and Bitcoin.
Dyne.org's Zenroom is the core component of the solution. Its portable and secure smart-contract execution environment works standalone (zero dependency) even in a web browser. It can be programmed in a language similar to plain English and guarantees to be functional and portable for two decades to come. Dr. Francesca Bria, president of the Italian National Innovation Fund Cassa Depositi e Prestiti comments: "Zenroom stands for Citizen Crypto. It is a core part of the DECODE tech stack for Smart Cities and it makes it easy to understand the complexity of data transformation while being compatible with any platform, including Legacy Infrastructure. We make Crypto for Citizens and we make it Open Source."
Each member of this consortium gathers together a mature experience developing and deploying industrial standards, as well as facilitating open source community adoption of technologies, including the presence in major blockchain standardisation initiatives such as ISO TC/307, INATBA, W3C and Sovrin.
The combination of blockchain-specific hardware solutions for critical infrastructures, developed by RIDDLE&CODE, will help turn data sources into trusted ones and lay the foundation for EBSI's automated processes and scalability. The combination of InfoCert's leadership and scale when providing services for digital trust, security and identity management complying with standards will allow Europe to adopt mature blockchain solutions to mission-critical environments.
For the initial phase of EBSI's procurement, the consortium proposes a revolutionary solution for a European Digital Product Passport. As a path to success, the consortium plans to work actively to create an open "playing field" in Europe that can easily integrate a diversity of solutions and open this promising industrial field to new players from the public and private sectors.
Quote from the consortium members:
● Andrea D'Intino (EBSI Project leader, Dyne.org): "The consortium's unique combined understanding of cryptography, blockchain and identity technologies as well as its global market positioning, give us the tools and the strength to bring EBSI to the next level. We are truly excited to embrace the policy makers, the businesses and the developers into an inclusive community, to fuel their ideas and products into the European Union's blockchain."
● Thomas Fürstner (Founder & CTO, RIDDLE&CODE): "The blockchain landscape diversifies into layer one and layer two technologies. Layer one is used for attesting values and identities with a small transaction payload and low frequency. Layer two is used for high-volume, low-value, day-to-day transactions. Then, there is the neglected but important layer zero, where blockchain meets products and goods of the physical world. This is exactly where RIDDLE&CODE contributes to EBSI."
● Carmine Auletta (Chief Strategy and Innovation Officer, InfoCert - Tinexta Group): "Being involved in shaping the future EU blockchain infrastructure not only makes us extremely proud, it also could have an important strategic impact on our reference market. An EU blockchain infrastructure could represent the backbone on which EU Trust will be built in the future." He further commented: "InfoCert, as the leading Qualified Trust Service Provider in the EU, aims to further strengthen its thought leadership role in a constantly evolving market. InfoCert has an impressive track record in building innovative solutions and an ambitious R&D program focused on Digital Identity and Digital Trust. It includes the exploitation of emerging technologies, among which blockchain is one of the most promising. Our partners have tremendous technical competencies in distributed ledger technologies, while InfoCert has very distinctive expertise in building Trust Frameworks. Joining forces was natural and proved to be crucial in the success of our consortium."
About RIDDLE&CODE
RIDDLE&CODE is Europe's leading company for blockchain interface solutions. The company develops hardware and software stacks that combine the security of smart cards with blockchain and the Internet of Things (IoT). Together with its tier-one clients and partners, which include Daimler Mobility, BMW, Wien Energie and leading Dutch crypto exchange LiteBit, RIDDLE&CODE brings new business models to the fintech, energy, mobility and materials industries.
More information: www.riddleandcode.com
About Dyne.org
Dyne.org is a non-profit foundation dedicated to free and open source software and community development with 20 years of expertise in developing applications used worldwide. Its motto is "we are free to share code and we code to share freedom" and other projects include independent streaming software for free speech, privacy tools for activists and GNU/Linux distributions.
More information: dyne.org
About InfoCert
InfoCert, Tinexta Group, is the largest European Certification Authority, active in over twenty countries. The company provides services in digitisation, eDelivery, Digital Signature and digital preservation of documents and is an accredited AgID digital identity operator in the area of SPID (Public System for the management of Digital Identity). The company holds a 51% stake in Camerfirma, one of the principal Spanish certification authorities and a 16.7% stake in Authada, a leading-edge German Identity Provider.
More information: infocert.digital
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210921005128/en/
Contact information
Media contact for RIDDLE&CODE:
Aysenur Yükselal Aji
aysenur@riddleandcode.com
Media contact for Dyne.org
Andrea D'Intino
info@dyne.org
Media contact for InfoCert
comunicazioni@infocert.it
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
